ScholarWorks@Korea University College of Medicine: Park, In Hae

Detailed Information

Park, In Hae (박인혜)

Guro Hospital (Department of Medical Oncology and Hematology, Guro Hospital)

Research Area: 유방암 치료, 임상시험, 중개 연구, breast cancer treatment, clinical trial, translational research

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

breast cancer:4||breast neoplasm:2||Breast cancer:2||HER2 positive:2||survivorship:2||realworld data:2||everolimus:2||molecular subtype:2||HippoYAP:1||Hormone receptorpositive:1||Metastatic breast cancer:1||Neoplasm metastasis:1||Neoplasms:1||Nextgeneration sequencing:1||Oral health:1||Palbociclib:1||Premenopausal women:1||Progressionfree survival:1||Risk:1||SMARCA4:1||TDM1:1||TAZ pathway:1||Tooth loss:1||Trastuzumab:1||Trastuzumab biosimilar:1||anthracycline:1||bone turnover markers:1||cancer drug:1||cancer patients:1||capecitabine:1||cardiotoxicity:1||cardiovascular disease:1||casecontrol study:1||chemotherapy:1||cisplatin resistance:1||consultation and referral:1||coronavirus disease 2019:1||ctDNA:1||data collection:1||disease free survival:1||epithelialtomesenchymal:1||estrogen receptor:1||exemestane:1||fertility preservation:1||genomewide association study:1||head and neck cancer:1||hormone receptorpositive:1||hydroxymethylglutarylCoA reductase inhibitors:1||isolated locoregional recurrence:1||medical record:1||metastatic breast cancer:1||palbociclib:1||patientreported outcome measures:1||perception:1||premenopausal women:1||premenopause:1||relevance:1||reliability:1||risk:1||safety:1||stroke:1||triplenegative breast cancer:1||vaccine:1||Biomarker:1||young age:1||Breast neoplasms:1||Cardiotoxicity:1||Clinical trial:1||Doxorubicin:1||Drug therapy:1||Everolimus:1||Heart failure:1||

STATISTICS: Total View :12,779,560; Today View :11,274

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE